Preclinical Assessment of Phage Therapy for Pathogen Decolonization
$437,000Y01FY2024AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
To support a variety of preclinical studies to assess the safety and efficacy of phage therapy for bacterial infections, including resistant infections.
View original record on NIH RePORTER →